Search

More Filters

Hidden H4 Anchor

Hidden H4 Anchor

Hidden H4 Anchor

3 results found for "tags:"Tisagenlecleucel""
Sort By: 

Web Page
Scientific Meeting Highlights from SITC

Annually, the Society for Immunotherapy of Cancer (SITC) publishes summaries of scientific meetings hosted throughout the year. These meeting highlights feature the latest research involving cancer immunotherapy. Browse below to view highlights from these meetings, including the society's own...

Added 06-12-2017
View Website
 
Year 2014 2015 2016 2017 2018 2019 2020 Source Abstracts Meeting Coverage Therapies Adoptive Cell Therapy Atezolizumab Avelumab Axicabtagene Ciloleucel Combination Therapy Cytokines Durvalumab Immune Checkpoint ... Ipilimumab Nivolumab Pembrolizumab Tisagenlecleucel Vaccines Therapeutic Effects Adverse Events Side Effects Toxicities Cancer Research Biomarkers Clinical Trials Immune Responsiveness Disease Bladder Cancer Bone Cancers Brain Cancers Breast Cancers Cervical Cancer Colon Cancer Colorectal Cancer Gastrointestinal Cancers Genitourinary Cancers Gynecologic Cancers Head and Neck Cancers Hematologic Malignancies Leukemia Lung Cancers Lymphoma Melanoma Merkel Cell Carcinoma Myeloma Neuroblastoma Non Small Cell Lung ... Ovarian Cancer Prostate Cancer Renal Cell Carcinoma Skin Cancers Small Cell Lung Cancer User Type Clinician Industry Oncologist Researcher Modality In Person Event Web Page

Web Page
About JITC

The Journal for ImmunoTherapy of Cancer (JITC) is the official journal of the Society for Immunotherapy of Cancer. This open access, peer-reviewed journal publishes original research articles, literature reviews, position papers and more on all aspects of tumor immunology and cancer...

Added 12-16-2016
View Website
 
Year 2015 Therapies Adoptive Cell Therapy Antibody Drug Conjugates Atezolizumab Avelumab Axicabtagene Ciloleucel Bacillus Calmette ... Bispecific Antibodies Blinatumomab Cemiplimab Colony Stimulating ... Combination Therapy Cytokines Durvalumab Imiquimod Immune Checkpoint ... Immunomodulators Ipilimumab Nivolumab Oncolytic Viruses Pembrolizumab Talimogene laherparepvec Therapeutic Antibodies Tisagenlecleucel Vaccines Therapeutic Effects Adverse Events Side Effects Toxicities User Type Allied Health Clinician Industry Oncologist Patient Patient Advocate Pharmacist Primary Care Physician Registered Nurse Researcher Cancer Research Antigen presenting cells B cells Biomarkers Clinical Trials Epigenetics Experimental Systems Genetics Immune Landscape Immune Responsiveness Immunogenic Cell Death Immunoscore Macrophages Microbiome Monoclonal Antibodies Mouse Models Natural killer cells Policy T cells Transcriptional Patterns Tumor Microenvironment Tumor mutational ... Disease Bladder Cancer Bone Cancers Brain Cancers Breast Cancers Cervical Cancer Colon Cancer Colorectal Cancer Gastrointestinal Cancers Genitourinary Cancers Gynecologic Cancers Head and Neck Cancers Hematologic Malignancies Leukemia Liver Cancer Lung Cancers Lymphoma Melanoma Merkel Cell Carcinoma Myeloma Neuroblastoma Non Small Cell Lung ... Ovarian Cancer Prostate Cancer Renal Cell Carcinoma Sarcomas Skin Cancers Small Cell Lung Cancer Administrative Operations Coverage and ... Modality Document Journal Article Web Page Source Journal for ... SITC
Showing 1-3 of 3 results